<DOC>
	<DOCNO>NCT02923960</DOCNO>
	<brief_summary>This randomize , double blind , multi treatment , crossover study intend compare glycemic insulinemic response consume liquid nutritional product people type 2 diabetes .</brief_summary>
	<brief_title>Effect Nutritional Products Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Subject type 2 diabetes Subject 's HbA1c , per point care device ≤ 8 % Subject male nonpregnant , nonlactating female , least 6 week postpartum prior screen visit Subject 's BMI &gt; 18.5 kg/m2 &lt; 35 kg/m2 If chronic medication antihypertensive , lipid lowering , thyroid medication hormone therapy , subject constant dosage least two month prior screen visit Subject state willingness follow protocol describe , include consumption study product per protocol completing require study form Participant must refrain take medications/dietary supplements/herbals substance could modulate glucose metabolism ( oral hypoglycemic medication ) , consider anabolic , reduce weight ( fat mass ) Subject currently diagnose , history severe dementia delirium , eat disorder , history significant neurological psychiatric disorder , alcoholism , substance abuse condition may interfere study product consumption compliance study protocol procedure Subject know allergic intolerant ingredient find study product Subject participate another study approve concomitant study Subject use exogenous insulin glucose control , subject state diagnose Type 1 diabetes Subject state history diabetic ketoacidosis Subject currently low carbohydrate low carbohydrate diet Subject currently prescribe , consume , αglucosidase inhibitor Subject state he/she current infection ; inpatient surgery , corticosteroid treatment last 3 month antibiotic last 3 week prior screen visit Subject state he/she active malignancy Subject state he/she significant cardiovascular event ≤ six month prior screen visit ; state history congestive heart failure Subject state he/she end stage organ failure status post organ transplant Subject diagnose chronic kidney disease , history kidney issue Subject state impair liver function , history liver disease Subject obstruction gastrointestinal tract preclude ingestion study product , inflammatory bowel disease , short bowel syndrome severe form gastrointestinal disease gastroesophageal reflux disease , gastroparesis , peptic ulcer disease , celiac disease , intestinal dysmotility , diverticulitis , ischemic colitis , related condition may cause unnecessary subject discomfort Subject state chronic , contagious , infectious disease Subject taken/is currently take herbal , dietary supplement , medication past four week prior screen visit design affect blood glucose . Subject state he/she clot bleeding disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>